Anti-5-LOX monoclonal antibody

Pre-made anti-5-LOX monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to 5-LOX/ALOX5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T00140-Ab-1/ GM-Tg-hg-T00140-Ab-2Anti-Human 5-LOX/ALOX5 monoclonal antibodyHuman
GM-Tg-rg-T00140-Ab-1/ GM-Tg-rg-T00140-Ab-2Anti-Rat 5-LOX/ALOX5 monoclonal antibodyRat
GM-Tg-mg-T00140-Ab-1/ GM-Tg-mg-T00140-Ab-2Anti-Mouse 5-LOX/ALOX5 monoclonal antibodyMouse
GM-Tg-cynog-T00140-Ab-1/ GM-Tg-cynog-T00140-Ab-2Anti-Cynomolgus/ Rhesus macaque 5-LOX/ALOX5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T00140-Ab-1/ GM-Tg-felg-T00140-Ab-2Anti-Feline 5-LOX/ALOX5 monoclonal antibodyFeline
GM-Tg-cang-T00140-Ab-1/ GM-Tg-cang-T00140-Ab-2Anti-Canine 5-LOX/ALOX5 monoclonal antibodyCanine
GM-Tg-bovg-T00140-Ab-1/ GM-Tg-bovg-T00140-Ab-2Anti-Bovine 5-LOX/ALOX5 monoclonal antibodyBovine
GM-Tg-equg-T00140-Ab-1/ GM-Tg-equg-T00140-Ab-2Anti-Equine 5-LOX/ALOX5 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T00140-Ab-1/ GM-Tg-hg-T00140-Ab-2; GM-Tg-rg-T00140-Ab-1/ GM-Tg-rg-T00140-Ab-2;
GM-Tg-mg-T00140-Ab-1/ GM-Tg-mg-T00140-Ab-2; GM-Tg-cynog-T00140-Ab-1/ GM-Tg-cynog-T00140-Ab-2;
GM-Tg-felg-T00140-Ab-1/ GM-Tg-felg-T00140-Ab-2; GM-Tg-cang-T00140-Ab-1/ GM-Tg-cang-T00140-Ab-2;
GM-Tg-bovg-T00140-Ab-1/ GM-Tg-bovg-T00140-Ab-2; GM-Tg-equg-T00140-Ab-1/ GM-Tg-equg-T00140-Ab-2
Products NameAnti-5-LOX/ALOX5 monoclonal antibody
Formatmab
Target Name5-LOX
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-5-LOX monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T00140-Ag-1Recombinant multi-species LOX5/ 5-LOX/ ALOX5 protein
    ORF Viral VectorvGMAP000506Human ALOX5 Adenovirus particle
    ORF Viral VectorpGMAP000506Human ALOX5 Adenovirus plasmid
    ORF Viral VectorpGMLV000885house mouse Alox5 Lentivirus plasmid
    ORF Viral VectorvGMLV000885house mouse Alox5 Lentivirus particle


    Target information

    Target IDGM-T00140
    Target Name5-LOX
    Gene ID240,11689,25290,707926,477753,101097422,404074,100062042
    Gene Symbol and Synonyms5-LO,5-LOX,5LO,5LPG,5LX,ALOX5,F730011J02,LOG5,LOX5A
    Uniprot AccessionP09917,P12527
    Uniprot Entry NameLOX5_HUMAN,LOX5_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000012779
    Target ClassificationTumor-associated antigen (TAA)

    The target: 5-LOX, gene name: ALOX5, also named as 5-LO, 5-LOX, 5LPG, LOG5. This gene encodes a member of the lipoxygenase gene family and plays a dual role in the synthesis of leukotrienes from arachidonic acid. The encoded protein, which is expressed specifically in bone marrow-derived cells, catalyzes the conversion of arachidonic acid to 5(S)-hydroperoxy-6-trans-8,11,14-cis-eicosatetraenoic acid, and further to the allylic epoxide 5(S)-trans-7,9-trans-11,14-cis-eicosatetrenoic acid (leukotriene A4). Leukotrienes are important mediators of a number of inflammatory and allergic conditions. Mutations in the promoter region of this gene lead to a diminished response to antileukotriene drugs used in the treatment of asthma and may also be associated with atherosclerosis and several cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.